loading
前日終値:
$3.41
開ける:
$3.42
24時間の取引高:
2.63M
Relative Volume:
0.54
時価総額:
$1.04B
収益:
$38.03M
当期純損益:
$-146.40M
株価収益率:
-6.6731
EPS:
-0.52
ネットキャッシュフロー:
$-121.38M
1週間 パフォーマンス:
-5.96%
1か月 パフォーマンス:
-37.81%
6か月 パフォーマンス:
+74.37%
1年 パフォーマンス:
+27.57%
1日の値動き範囲:
Value
$3.33
$3.55
1週間の範囲:
Value
$3.33
$3.83
52週間の値動き範囲:
Value
$1.8906
$6.515

Abcellera Biologics Inc Stock (ABCL) Company Profile

Name
名前
Abcellera Biologics Inc
Name
セクター
Healthcare (1139)
Name
電話
(604) 559-9005
Name
住所
150 W 4TH AVENUE, VANCOUVER
Name
職員
596
Name
Twitter
Name
次回の収益日
2024-11-18
Name
最新のSEC提出書
Name
ABCL's Discussions on Twitter

ABCL を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ABCL
Abcellera Biologics Inc
3.47 1.02B 38.03M -146.40M -121.38M -0.52
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
435.06 107.15B 11.74B 3.68B 3.34B 14.19
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
761.11 77.46B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
437.57 58.90B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
922.65 56.55B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
200.09 42.58B 447.02M -1.18B -906.14M -6.1812

Abcellera Biologics Inc Stock (ABCL) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-11-07 ダウングレード Leerink Partners Outperform → Market Perform
2025-07-07 再開されました Leerink Partners Outperform
2024-08-20 ダウングレード The Benchmark Company Buy → Hold
2024-02-22 アップグレード The Benchmark Company Hold → Buy
2023-12-05 開始されました KeyBanc Capital Markets Overweight
2023-11-06 ダウングレード The Benchmark Company Buy → Hold
2023-10-13 再開されました Piper Sandler Overweight
2023-02-28 開始されました Cowen Outperform
2022-12-15 開始されました Goldman Buy
2022-11-16 開始されました Truist Buy
2021-12-21 開始されました The Benchmark Company Buy
2021-11-19 開始されました Piper Sandler Overweight
2021-01-05 開始されました BMO Capital Markets Outperform
2021-01-05 開始されました Berenberg Buy
2021-01-05 開始されました Credit Suisse Outperform
2021-01-05 開始されました SVB Leerink Outperform
2021-01-05 開始されました Stifel Buy
すべてを表示

Abcellera Biologics Inc (ABCL) 最新ニュース

pulisher
04:56 AM

How AbCellera Biologics Inc. (8QQ) stock correlates with oil marketsJuly 2025 Price Swings & Expert Curated Trade Setups - newser.com

04:56 AM
pulisher
03:50 AM

Is AbCellera Biologics Inc a good long term investmentStock Price Targets & Low Risk Wealth Building - earlytimes.in

03:50 AM
pulisher
03:50 AM

Is AbCellera Biologics Inc. (8QQ) stock safe for risk averse investors2025 Fundamental Recap & AI Driven Stock Reports - newser.com

03:50 AM
pulisher
Nov 20, 2025

How AbCellera Biologics Inc. (8QQ) stock compares with market leadersJuly 2025 Pullbacks & Verified Momentum Stock Watchlist - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will AbCellera Biologics Inc. (8QQ) stock outperform energy sector in 2025Market Trend Summary & High Conviction Buy Zone Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

How AbCellera Biologics Inc. (8QQ) stock reacts to weak economy2025 Trading Volume Trends & Safe Entry Zone Identification - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Is AbCellera Biologics Inc. (8QQ) stock at risk of policy regulationJobs Report & Daily Entry Point Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can AbCellera Biologics Inc. (8QQ) stock resist broad market declinesMarket Volume Report & Accurate Intraday Trade Tips - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

AbCellera Biologics’ Earnings Call: Key Insights - MSN

Nov 19, 2025
pulisher
Nov 19, 2025

How AbCellera Biologics Inc. stock reacts to Fed rate cutsAnalyst Upgrade & Expert Curated Trade Setups - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is a relief rally coming for AbCellera Biologics Inc. holdersDollar Strength & Fast Gain Stock Trading Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What’s next for AbCellera Biologics Inc. stock priceQuarterly Investment Review & Capital Efficient Trade Techniques - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will AbCellera Biologics Inc. stock reach Wall Street targetsWeekly Risk Report & Free Risk Controlled Daily Trade Plans - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What makes AbCellera Biologics Inc. (8QQ) stock appealing to growth investors2025 Market Trends & Scalable Portfolio Growth Methods - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is AbCellera Biologics Inc. (8QQ) stock considered safe haven2025 Price Action Summary & Verified Momentum Stock Ideas - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Is AbCellera Biologics Inc. (8QQ) stock dividend growth reliableMarket Sentiment Summary & High Return Trade Opportunity Guides - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Why AbCellera Biologics Inc. (8QQ) stock stays on buy listsQuarterly Investment Review & Low Risk Investment Opportunities - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Real time breakdown of AbCellera Biologics Inc. stock performanceDollar Strength & Safe Investment Capital Preservation Plans - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

Will AbCellera Biologics Inc. stock maintain momentum in 2025Weekly Gains Summary & Safe Entry Point Identification - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Will AbCellera Biologics Inc. (8QQ) stock hit Wall Street targetsAnalyst Downgrade & Weekly Top Gainers Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Will AbCellera Biologics Inc. see short term momentum2025 Top Decliners & AI Driven Stock Reports - newser.com

Nov 18, 2025

Abcellera Biologics Inc (ABCL) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$39.04
price up icon 1.64%
$30.68
price up icon 2.13%
$102.37
price up icon 0.68%
$96.31
price down icon 0.70%
biotechnology ONC
$347.71
price down icon 0.53%
$200.38
price up icon 0.08%
大文字化:     |  ボリューム (24 時間):